Par Drugs And Chemicals vs Nifty 50: Returns Compared

Par Drugs And Chemicals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Par Drugs And Chemicals trades on the NSE under the symbol PAR, and its 1-month return of -9.60% compares with -5.12% for the Nifty 50 over the same period.

The Par Drugs And Chemicals vs Nifty 50 comparison matters because Par Drugs And Chemicals is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Par Drugs And Chemicals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 8 October 2026.

Also read – Pine Labs vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Par Drugs And Chemicals vs Nifty 50: Performance at a Glance

The table below sets out the Par Drugs And Chemicals vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.

Time Frame	Par Drugs And Chemicals Return	Nifty 50 Return	Difference
1 Month	-9.60%	-5.12%	-4.48 pp
3 Months	+35.54%	-7.22%	+42.76 pp
6 Months	+33.10%	-6.49%	+39.59 pp
1 Year	+17.87%	-11.71%	+29.58 pp
3 Years	-39.55%	+13.94%	-53.49 pp

On the Par Drugs And Chemicals vs Nifty 50 scorecard, Par Drugs And Chemicals has beaten the index over the latest 1-year window, returning +17.87% against -11.71% for the Nifty 50, a difference of 29.58 percentage points. The widest gap on the table is over three years, where Par Drugs And Chemicals fell 39.55% while the Nifty 50 gained 13.94%, a difference of 53.49 percentage points against the stock. The direction differs over the past year: Par Drugs And Chemicals moved up while the Nifty 50 moved down.

Check the Univest Screener for live Par Drugs And Chemicals and Nifty 50 data

Latest Close and 52-Week Range: Par Drugs And Chemicals and the Nifty 50

Instrument	Latest Close	52-Week High	52-Week Low	Vs 52-Week High
Par Drugs And Chemicals	Rs 121.47	Rs 180.00	Rs 78.05	-32.5%
Nifty 50	22,231.80	26,373.20	22,179.90	-15.7%

Par Drugs And Chemicals closed at Rs 121.47 on 8 October 2026, which is 32.5% below its 52-week high of Rs 180.00 and 55.6% above its 52-week low of Rs 78.05. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Par Drugs And Chemicals vs Nifty 50 Gap Exists

Par Drugs And Chemicals can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Par Drugs And Chemicals has traded between Rs 78.05 and Rs 180.00, a spread of 130.6% from low to high, against 18.9% for the Nifty 50.

Sector sentiment and trading liquidity add to the gap in the Par Drugs And Chemicals vs Nifty 50 comparison. When buying interest surges or dries up in Par Drugs And Chemicals, the price can move several percent in a single session, whereas the Nifty 50 absorbs flows across 50 heavily traded stocks.

Download the Univest iOS App or Univest Android App to track Par Drugs And Chemicals and Nifty 50 live on the go.

Par Drugs And Chemicals vs Nifty 50: Has Par Drugs And Chemicals Beaten the Benchmark?

Yes, over the past year. Par Drugs And Chemicals returned +17.87% against -11.71% for the Nifty 50, a lead of 29.58 percentage points. Across the five time frames measured, Par Drugs And Chemicals is ahead of the index over 3 months, 6 months and 1 year and behind it over 1 month and 3 years.

Risks of the Par Drugs And Chemicals vs Nifty 50 Comparison

Point-to-point returns can mislead, and the Par Drugs And Chemicals vs Nifty 50 comparison is no exception. A different start date would shift every figure in the table above, and past performance does not indicate how either Par Drugs And Chemicals or the Nifty 50 will perform from here.

Also read – PC Jeweller vs Nifty 50: Returns Compared

Par Drugs And Chemicals carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 78.05 to Rs 180.00 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Par Drugs And Chemicals vs Nifty 50 shows Par Drugs And Chemicals ahead of the index in 3 of 5 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Par Drugs And Chemicals into a wider portfolio.

Has Par Drugs And Chemicals outperformed the Nifty 50 in the last year?

Ans. Yes. Par Drugs And Chemicals returned +17.87% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.

How does Par Drugs And Chemicals vs Nifty 50 look over 3 years?

Ans. Over three years Par Drugs And Chemicals has returned -39.55% compared with the Nifty 50's +13.94%, so in the Par Drugs And Chemicals vs Nifty 50 comparison the stock has been behind over this horizon.

What is the Par Drugs And Chemicals share price today compared to Nifty 50?

Ans. Par Drugs And Chemicals share price closed at Rs 121.47 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.

What is the 52-week high and low of Par Drugs And Chemicals?

Ans. Par Drugs And Chemicals's 52-week high is Rs 180.00 and its 52-week low is Rs 78.05, based on NSE data. The latest close of Rs 121.47 is 32.5% below the high.

Why does Par Drugs And Chemicals show bigger price swings than the Nifty 50?

Ans. Par Drugs And Chemicals carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Par Drugs And Chemicals has traded in a 130.6% low-to-high range against 18.9% for the index, a key reason the Par Drugs And Chemicals vs Nifty 50 return gap varies across time frames.

Is Par Drugs And Chemicals a good long-term investment compared to a Nifty 50 index fund?

Ans. Par Drugs And Chemicals's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Par Drugs And Chemicals vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.